A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DARPP-32 / dopamine- and cAMP-regulated phosphoprotein of 32 kDa

[Related PubMed/MEDLINE]
Total Number of Papers: 182
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DARPP-32  (>> Co-occurring Abbreviation)
Long Form:   dopamine- and cAMP-regulated phosphoprotein of 32 kDa
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 The expression of tyrosine hydroxylase and DARPP-32 in the house crow (Corvus splendens) brain. TH
2018 Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease. BDNF, HD, NPY, Y2R
2018 cJun N-terminal kinase (JNK) mediates cortico-striatal signaling in a model of Parkinson's disease. D1R, JNK, NMDA, PD
2018 Effects of the -141C insertion/deletion polymorphism in the dopamine D2 receptor gene on the dopamine system in the striatum in patients with schizophrenia. CaN
2018 Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerations. cAMP, cGMP, CREB, PDE inhibitors, PKA, PKG
2018 Toll-like receptor-4 regulates anxiety-like behavior and DARPP-32 phosphorylation. BDNF, KO, mGluRs, TLRs
2017 Delta9-Tetrahydrocannabinol Experience Influences DeltaFosB and Downstream Gene Expression in Prefrontal Cortex. Cdk5, ERK, GSK3beta, mRNA, NAc, PFC, THC
2017 Immunocytochemical characterisation of neural stem-progenitor cells from green terror cichlid Aequidens rivulatus. GFAP, NSPC, OPC
2017 Intrastriatal injection of ionomycin profoundly changes motor response to l-DOPA and its underlying molecular mechanisms. LID
10  2017 Modulation of Low-Voltage-Activated Inward Current Permeable to Sodium and Calcium by DARPP-32 Drives Spontaneous Firing of Insect Octopaminergic Neurosecretory Cells. ATP, DUM, LVA, OA, OAR, PKA, TAG
11  2017 Muscarinic acetylcholine M4 receptors play a critical role in oxotremorine-induced DARPP-32 phosphorylation at threonine 75 in isolated medium spiny neurons. DA, mAChRs, MSNs, OX
12  2017 The involvement of DARPP-32 in the pathophysiology of schizophrenia. ---
13  2017 The Schizophrenia-Associated BRD1 Gene Regulates Behavior, Neurotransmission, and Expression of Schizophrenia Risk Enriched Gene Sets in Mice. cAMP, Chrm4, CREB, DRD2, TCF4
14  2016 Basal Ganglia Damage in Experimental Subarachnoid Hemorrhage. SAH
15  2016 DARPP-32: from neurotransmission to cancer. PKA, PP1, PPP1R1B
16  2016 Differential regulation of the phosphorylation of Trimethyl-lysine27 histone H3 at serine 28 in distinct populations of striatal projection neurons. MSK1, PcG
17  2016 DSM-5 from the viewpoint of basic study of dependence and addiction. ---
18  2016 Effects and molecular mechanism of chitosan-coated levodopa nanoliposomes on behavior of dyskinesia rats. AIM, LID
19  2016 Gastric tumour-derived ANGPT2 regulation by DARPP-32 promotes angiogenesis. ANGPT2, STAT3
20  2016 PPARalpha modulation of mesolimbic dopamine transmission rescues depression-related behaviors. NAcS, PPARalpha, VTA
21  2016 Regulation of Nociceptive Plasticity Threshold and DARPP-32 Phosphorylation in Spinal Dorsal Horn Neurons by Convergent Dopamine and Glutamate Inputs. D1LRs, LTP
22  2015 Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by L-DOPA? COX2, NO
23  2015 Calpain-mediated cleavage of DARPP-32 in Alzheimer's disease. AD, CREB, PP1
24  2015 Delayed post-treatment with bone marrow-derived mesenchymal stem cells is neurorestorative of striatal medium-spiny projection neurons and improves motor function after neonatal rat hypoxia-ischemia. BrdU, MSC, MSCs, PN
25  2015 High Expression of DARPP-32 in Colorectal Cancer Is Associated With Liver Metastases and Predicts Survival for Dukes A and B Patients: Results of a Pilot Study. ---
26  2015 Impramine, fluoxetine and clozapine differently affected reactivity to positive and negative stimuli in a model of motivational anhedonia in rats. BP, NAcS, SA
27  2015 Motor Skill Learning Is Associated with Phase-Dependent Modifications in the Striatal cAMP/PKA/DARPP-32 Signaling Pathway in Rodents. CREB, mPFC
28  2015 Role of Dopamine Type 1 Receptors and Dopamine- and cAMP-Regulated Phosphoprotein Mr 32 kDa in Delta9-Tetrahydrocannabinol-Mediated Induction of DeltaFosB in the Mouse Forebrain. D1R, DeltaFosB, KO, WT
29  2015 Serotonin2C receptor stimulation inhibits cocaine-induced Fos expression and DARPP-32 phosphorylation in the rat striatum independently of dopamine outflow. DA, i.p, NAc
30  2015 Serotonin2C receptors modulate dopamine transmission in the nucleus accumbens independently of dopamine release: behavioral, neurochemical and molecular studies with cocaine. DA, NAc
31  2014 A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson's disease. c-Abl, Cdk5, PD
32  2014 Elevated postmortem striatal t-DARPP expression in schizophrenia and associations with DRD2/ANKK1 polymorphism. ANKK1, CaN
33  2014 Evaluation of NCS-1, DARPP-32, and neurotrophins in hippocampus and prefrontal cortex in rats submitted to sepsis. BDNF, NGF
34  2014 Experimental traumatic brain injury alters ethanol consumption and sensitivity. APP, GFAP, TBI
35  2014 Feedback regulation mediated by Bcl-2 and DARPP-32 regulates inositol 1,4,5-trisphosphate receptor phosphorylation and promotes cell survival. CaN, PKA, PP1
36  2014 GDNF is important for striatal organization and maintenance of dopamine neurons grown in the presence of the striatum. GDNF, LGE, MRI, TH, VM
37  2014 Genetic polymorphisms regulating dopamine signaling in the frontal cortex interact to affect target detection under high working memory load. COMT, DA
38  2014 Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice. CaMKII, MPTP, TH
39  2014 Striatal neurodevelopment is dysregulated in purine metabolism deficiency and impacts DARPP-32, BDNF/TrkB expression and signaling: new insights on the molecular and cellular basis of Lesch-Nyhan Syndrome. Bcl11b, HPRT, LNS, ROS
40  2014 The CB1 cannabinoid receptor agonist reduces L-DOPA-induced motor fluctuation and ERK1/2 phosphorylation in 6-OHDA-lesioned rats. L-DOPA, PD
41  2013 Association between PPP1R1B polymorphisms and defense mechanisms in healthy Chinese-Han subjects. ---
42  2013 Crosstalk between dopamine D₂ receptors and cannabinoid CB₁ receptors regulates CNR1 promoter activity via ERK1/2 signaling. 5'-UTR, CNR1
43  2013 DARPP-32 to quantify intracerebral hemorrhage-induced neuronal death in basal ganglia. ICH
44  2013 Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus. cAMP, CREB, D3R, DA, GSK-3beta, mBDNF, PKA, proBDNF, qRT-PCR, tPA
45  2013 Haloperidol promotes mTORC1-dependent phosphorylation of ribosomal protein S6 via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1. D2Rs, MSNs, mTORC1, PP1, rpS6, S6K1
46  2013 Induction of DARPP-32 by brain-derived neurotrophic factor in striatal neurons in vitro is modified by histone deacetylase inhibitors and Nab2. BDNF
47  2013 Influence of palatability on motivation to operate for caloric and non-caloric food in non food-deprived and food-deprived rats. NAcS
48  2013 Loss of DARPP-32 and calbindin in multiple system atrophy. MSA, p-syn
49  2013 Methylphenidate restores novel object recognition in DARPP-32 knockout mice. ---
50  2013 mGlu5R promotes glutamate AMPA receptor phosphorylation via activation of PKA/DARPP-32 signaling in striatopallidal medium spiny neurons. A2ARs, DHPG, mGluRs, MPEP, MSNs, PKA
51  2013 Microtransplantation of whole ganglionic eminence cells ameliorates motor deficit, enlarges the volume of grafts, and prolongs survival in a rat model of Huntington's disease. GFAP, HD, NeuN, QA, WGE
52  2013 Postnatal maternal deprivation and pubertal stress have additive effects on dopamine D2 receptor and CaMKII beta expression in the striatum. CaMKIIbeta, D2R, MD, NKB
53  2013 Regulation of CXCR4-mediated invasion by DARPP-32 in gastric cancer cells. MT1-MMP
54  2013 T2 and T2* magnetic resonance imaging sequences predict brain injury after intracerebral hemorrhage in rats. ICH, MRI
55  2012 Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain. Cdk5, ERK
56  2012 DARPP-32 is required for MAPK/ERK signaling in thyroid cells. ---
57  2012 Dopamine D1 receptor-mediated intracellular responses in the hypothalamus after co-administration of caffeine with MDMA. CREB, MDMA
58  2012 Dopamine- and cAMP-regulated phosphoprotein of 32-kDa (DARPP-32)-dependent activation of extracellular signal-regulated kinase (ERK) and mammalian target of rapamycin complex 1 (mTORC1) signaling in experimental parkinsonism. D1R, ERK, l-DOPA, MSNs, mTORC1
59  2012 Effects of nicotine administration on striatal dopamine signaling after traumatic brain injury in rats. TBI
60  2012 Environmental enrichment alters nicotine-mediated locomotor sensitization and phosphorylation of DARPP-32 and CREB in rat prefrontal cortex. CREB, EC, PFC
61  2012 Naloxonazine, a specific mu-opioid receptor antagonist, attenuates the increment of locomotor activity induced by acute methamphetamine in mice. METH
62  2012 Regulation of ERBB2 receptor by t-DARPP mediates trastuzumab resistance in human esophageal adenocarcinoma. EAC, t-DARPP
63  2012 Resistance to TRAIL is mediated by DARPP-32 in gastric cancer. ---
64  2012 Striatal neuronal loss correlates with clinical motor impairment in Huntington's disease. HD
65  2011 Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia. IR, MMN, NMDA, STG, Thr
66  2011 Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling. D1Rs, MSNs
67  2011 Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia: an immunohistochemical study. DLPFC, IR
68  2011 L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission. D1R, ERK, LID, MSNs, mTORC1, PKA
69  2011 Molecular adaptations of apoptotic pathways and signaling partners in the cerebral cortex of human cocaine addicts and cocaine-treated rats. AIF, FADD, Fas, PARP-1, PFC, t-DARPP
70  2011 Organophosphates dysregulate dopamine signaling, glutamatergic neurotransmission, and induce neuronal injury markers in striatum. AMPA, CPF, DEET, GluR1, OP, PKA
71  2011 Postnatal development of tyrosine hydroxylase mRNA-expressing neurons in mouse neostriatum. EGFP, MSNs, TH
72  2011 Profiles of DARPP-32 in the insular cortex with schizophrenia: a postmortem brain study. GABA, IR, PMI, RAIC
73  2011 Relation of addiction genes to hypothalamic gene changes subserving genesis and gratification of a classic instinct, sodium appetite. ACTH, ARC, STEP
74  2011 Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice. HD, SST
75  2011 The dopamine and cAMP regulated phosphoprotein, 32 kDa (DARPP-32) signaling pathway: a novel therapeutic target in traumatic brain injury. NMDA, TBI
76  2010 Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. ---
77  2010 Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis. CES
78  2010 Effect of cdk5 antagonist on L-dopa-induced dyskinesias in a rat model of Parkinson's disease. AIM, Cdk5, LID, PD
79  2010 Glial cell line-derived neurotrophic factor is crucial for long-term maintenance of the nigrostriatal system. GDNF, LGE, TH, VM
80  2010 Localization of dopamine- and cAMP-regulated phosphoprotein-32 and inhibitor-1 in area 9 of Macaca mulatta prefrontal cortex. D1R, PFC, PKA, PP1
81  2010 Modifications in DARPP-32 phosphorylation pattern after repeated palatable food consumption undergo rapid habituation in the nucleus accumbens shell of non-food-deprived rats. ---
82  2010 Preparation of a novel monoclonal antibody specific to DARPP-32. ELISA
83  2010 Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons. PKA
84  2010 Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat. AIMS, l-DOPA, LID, PD, PKA
85  2009 Basal and cocaine-induced sex differences in the DARPP-32-mediated signaling pathway. P-Thr34-DARPP-32, PP1, PP2B
86  2009 Caffeine and a selective adenosine A2A receptor antagonist induce reward and sensitization behavior associated with increased phospho-Thr75-DARPP-32 in mice. CPP, DPCPX
87  2009 Dopamine D1 receptor-dependent modifications in the dopamine and cAMP-regulated phosphoprotein of Mr 32 kDa phosphorylation pattern in striatal areas of morphine-sensitized rats. PKA, Thr
88  2009 Dopamine depletion induces distinct compensatory gene expression changes in DARPP-32 signal transduction cascades of striatonigral and striatopallidal neurons. PD
89  2009 Early life exposure to a high fat diet promotes long-term changes in dietary preferences and central reward signaling. ---
90  2009 Early long-term exposure with caffeine induces cross-sensitization to methylphenidate with involvement of DARPP-32 in adulthood of rats. ADHD, MPH
91  2009 Effects of electroconvulsive shock on the phosphorylation of DARPP-32 in rat striatum. Cdk5, ECS, PP1
92  2009 Molecular mechanisms of psychostimulant addiction. ---
93  2009 PKA-mediated responses in females' estrous cycle affect cocaine-induced responses in dopamine-mediated intracellular cascades. CPu, NAc
94  2009 Protein components of the blood-brain barrier (BBB) in the brainstem area postrema-nucleus tractus solitarius region. alpha-MSH, AP, BBB, CVOs, EBA, GFAP, GLUT1, NPY, NTS, RECA-1, SMA, TfR, ZO-1
95  2009 Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling. AMPA, NMDA, PFC, PKA
96  2009 Tissue plasminogen activator modulates the cellular and behavioral response to cocaine. CPP, CREB, CRFR1, IEGs, NAc, ppDyn, tPA
97  2009 Wnt-5a-induced phosphorylation of DARPP-32 inhibits breast cancer cell migration in a CREB-dependent manner. DN-CREB, PKA, PP1
98  2008 Caffeine and other sympathomimetic stimulants: modes of action and effects on sports performance. ---
99  2008 Differences between dorsal and ventral striatum in Drd1a dopamine receptor coupling of dopamine- and cAMP-regulated phosphoprotein-32 to activation of extracellular signal-regulated kinase. PD
100  2008 Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. PDE, PKA, TH